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Malignant peripheral nerve sheath tumors (MPNSTs) are defined as any malignant tumor arising from or differentiating toward cells of the peripheral nerve sheath. They are very rare tumors, with an incidence of 1 per 100,000 population.
[1] The World Health Organization (WHO) coined the term MPNST, replacing previous heterogeneous and often confusing terminology such as malignant schwannoma, malignant neurilemmoma and neurofibrosarcoma for tumors of neurogenic origin and similar biological behavior. [2] Malignant peripheral nerve sheath tumors have a tendency to recur locally and spread hematogenously.
[3] Alhough they are biologically aggressive, surgery is the mainstay of treatment. [3] Despite aggressive surgery and adjuvant therapy, the prognosis for patients with MPNST remains poor. [4, 5] Malignant peripheral nerve sheath tumors arise from major or minor peripheral nerve branches or sheaths of peripheral nerve fibers.
[6] The trunk and extremities are the commonest sites involved. [3] Malignant peripheral nerve sheath tumors are rarely encountered in the head and neck region. A patient who had been diagnosed and treated for MPNST of the lower lip was presented in this study.
